Synthesis of Nanoparticles for Plasmonics Applications: A Microfluidic Approach

Opportunities and Challenges in the Synthesis of Noble Metal Nanoparticles via the Chemical Route in Microreactor Systems

The process of noble metal nanoparticle synthesis is complex and consists of at least two steps: slow nucleation and fast autocatalytic growth. The kinetics of these two processes depends on the reductant "power" and the addition of stabilizers, as well as other factors (e.g., temperature, pH, ionic strength). Knowing these parameters, it is possible to synthesize materials with appropriate physicochemical properties, which can be simply adjusted by the type of the used metal, particle morphology and surface property. This, in turn, affects the possibility of their applications in various areas of life, including medicine, catalysis, engineering, fuel cells, etc. However, in some cases, the standard route, i.e., the chemical reduction of a metal precursor carried out in the batch reactor, is not sufficient due to problems with temperature control, properties of reagents, unstable or dangerous intermediates and products, etc. Therefore, in this review, we focused on an alternative approach to their chemical synthesis provided by microreactor systems. The use of microreactors for the synthesis of noble metal nanomaterials (e.g., Ag, Au, Pt, Pd), obtained by chemical reduction, is analyzed, taking into account investigations carried out in recent years. A particular emphasis is placed on the processes in which the use of microreactors removed the limitations associated with synthesis in a batch reactor. Moreover, the opportunities and challenges related to the synthesis of noble nanomaterials in the microreactor system are underlined. This review discusses the advantages as well as the problems of nanoparticle synthesis in microreactors.

Microfluidic SERS devices: brightening the future of bioanalysis

A new avenue has opened up for applications of surface-enhanced Raman spectroscopy (SERS) in the biomedical field, mainly due to the striking advantages offered by SERS tags. SERS tags provide indirect identification of analytes with rich and highly specific spectral fingerprint information, high sensitivity, and outstanding multiplexing potential, making them very useful in in vitro and in vivo assays. The recent and innovative advances in nanomaterial science, novel Raman reporters, and emerging bioconjugation protocols have helped develop ultra-bright SERS tags as powerful tools for multiplex SERS-based detection and diagnosis applications. Nevertheless, to translate SERS platforms to real-world problems, some challenges, especially for clinical applications, must be addressed. This review presents the current understanding of the factors influencing the quality of SERS tags and the strategies commonly employed to improve not only spectral quality but the specificity and reproducibility of the interaction of the analyte with the target ligand. It further explores some of the most common approaches which have emerged for coupling SERS with microfluidic technologies, for biomedical applications. The importance of understanding microfluidic production and characterisation to yield excellent device quality while ensuring high throughput production are emphasised and explored, after which, the challenges and approaches developed to fulfil the potential that SERS-based microfluidics have to offer are described.